Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

945 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial.
McCoy J, Goren A, Cadegiani FA, Vaño-Galván S, Kovacevic M, Situm M, Shapiro J, Sinclair R, Tosti A, Stanimirovic A, Fonseca D, Dorner E, Onety DC, Zimerman RA, Wambier CG. McCoy J, et al. Among authors: tosti a. Front Med (Lausanne). 2021 Jul 19;8:668698. doi: 10.3389/fmed.2021.668698. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34350193 Free PMC article. Retracted.
Follow up of 12 patients with trachyonychia.
Sakata S, Howard A, Tosti A, Sinclair R. Sakata S, et al. Among authors: tosti a. Australas J Dermatol. 2006 Aug;47(3):166-8. doi: 10.1111/j.1440-0960.2006.00264.x. Australas J Dermatol. 2006. PMID: 16866995
Frequency of the Types of Alopecia at Twenty-Two Specialist Hair Clinics: A Multicenter Study.
Vañó-Galván S, Saceda-Corralo D, Blume-Peytavi U, Cucchía J, Dlova NC, Gavazzoni Dias MFR, Grimalt R, Guzmán-Sánchez D, Harries M, Ho A, Holmes S, Larrondo J, Mosam A, Oliveira-Soares R, Pinto GM, Piraccini BM, Pirmez R, De la Rosa Carrillo D, Rudnicka L, Shapiro J, Sinclair R, Tosti A, Trüeb RM, Vogt A, Miteva M. Vañó-Galván S, et al. Among authors: tosti a. Skin Appendage Disord. 2019 Aug;5(5):309-315. doi: 10.1159/000496708. Epub 2019 Apr 2. Skin Appendage Disord. 2019. PMID: 31559256 Free PMC article.
Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men.
Goren A, Wambier CG, Herrera S, McCoy J, Vaño-Galván S, Gioia F, Comeche B, Ron R, Serrano-Villar S, Ramos PM, Cadegiani FA, Kovacevic M, Tosti A, Shapiro J, Sinclair R. Goren A, et al. Among authors: tosti a. J Eur Acad Dermatol Venereol. 2021 Jan;35(1):e13-e15. doi: 10.1111/jdv.16953. Epub 2020 Oct 21. J Eur Acad Dermatol Venereol. 2021. PMID: 32977363 Free PMC article. No abstract available.
Clinical symptoms of hyperandrogenic women diagnosed with COVID-19.
Cadegiani FA, Lim RK, Goren A, McCoy J, Situm M, Kovacevic M, Vañó Galván S, Sinclair R, Tosti A, Wambier CG. Cadegiani FA, et al. Among authors: tosti a. J Eur Acad Dermatol Venereol. 2021 Feb;35(2):e101-e104. doi: 10.1111/jdv.17004. Epub 2020 Nov 8. J Eur Acad Dermatol Venereol. 2021. PMID: 33089570 No abstract available.
5-alpha-reductase inhibitors are associated with reduced frequency of COVID-19 symptoms in males with androgenetic alopecia.
McCoy J, Cadegiani FA, Wambier CG, Herrera S, Vaño-Galván S, Mesinkovska NA, Ramos PM, Shapiro J, Sinclair R, Tosti A, Goren A. McCoy J, et al. Among authors: tosti a. J Eur Acad Dermatol Venereol. 2021 Apr;35(4):e243-e246. doi: 10.1111/jdv.17021. Epub 2020 Nov 22. J Eur Acad Dermatol Venereol. 2021. PMID: 33135263 No abstract available.
Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster.
Goren A, Cadegiani FA, Wambier CG, Vano-Galvan S, Tosti A, Shapiro J, Mesinkovska NA, Ramos PM, Sinclair R, Lupi O, Hercogova J, McCoy J. Goren A, et al. Among authors: tosti a. Med Hypotheses. 2021 Jan;146:110439. doi: 10.1016/j.mehy.2020.110439. Epub 2020 Nov 28. Med Hypotheses. 2021. PMID: 33308937 Free PMC article. No abstract available.
Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial.
Cadegiani FA, McCoy J, Gustavo Wambier C, Vaño-Galván S, Shapiro J, Tosti A, Zimerman RA, Goren A. Cadegiani FA, et al. Among authors: tosti a. Cureus. 2021 Feb 22;13(2):e13492. doi: 10.7759/cureus.13492. Cureus. 2021. PMID: 33633920 Free PMC article.
945 results